...FDA approved T2 Biosystems' T2Candida Panel and T2Dx Instrument to detect and identify 5 species of Candida... ...would not be cleared via the 510(k) pathway. T2 Biosystems Inc. (NASDAQ:TTOO), Lexington, Mass. Product: T2Candida Panel...
...series D round this month to support an FDA submission for its first product, a Candida test... ...is approved, according to McDonough. "Infectious disease societies have understood the importance of having a Candida test...
Diagnostic company T2 Biosystems Inc. (Lexington, Mass.) raised $23 million in a series D round led by new investor Aisling Capital. Existing investors Flagship Ventures; Polaris Venture Partners; Flybridge Capital Partners; Physic Ventures; Partners Healthcare;...
